Mendelian sampling covariability of marker effects and genetic values

Sarah Bonk, Manuela Reichelt, F. Teuscher, +2

Genetics Selection Evolution

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

Sarah Bonk, Martina Kluth, Claudia Hube‐Magg, +20

Oncotarget

Individualized Early Goal-Directed Therapy in Systemic Inflammation

Karin Wodack, Annika Poppe, Tomköetter Lena, +12

Critical Care Medicine

Posttraumatic stress disorder is associated with reduced vitamin D levels and functional polymorphisms of the vitamin D binding-protein in a population-based sample

Jan Terock, Anke Hannemann, Sandra Van der Auwera, +5

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Psychological Co-morbiditiesPsychoneuroimmunologyPsychiatryStressComorbid Psychiatric Disorder +10

Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG‐negative prostate cancer

Sarah Bonk, Martina Kluth, Kristina Jansen, +17

The Prostate

Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease

Kevin Kirchner, Linda Garvert, Annemarie Luise Kühn, +3

Cells

High B7‐H3 expression is linked to increased risk of prostate cancer progression

Sarah Bonk, Pinar Tasdelen, Martina Kluth, +17

Pathology International

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

Andreas H. Marx, Lena Koopmann, Doris Höflmayer, +17

Cancer Biology and Medicine

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

Jan Meiners, Katharina Schulz, Katharina M�ller, +25

Oncology Letters

Nuclear Spdef ExpressionUrologySpdef ExpressionGenitourinary CancerMedicine +10

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

Franziska Büscheck, Mariam Sulimankhil, Nathaniel Melling, +24

Cancer Medicine